We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.19 | 2.97% | 6.59 | 6.20 | 6.98 | - | 196,136 | 16:35:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.73 | 12.89M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 16/4/2021 19:09 | This is my last big Covid holding. Hoping for good news very soon! I am concerned that Activ 2 is struggling to recruit (why has it taken 2 months?) and this will get harder now that 35% of USA are vaccinated. Nevertheless I am holding long and strong as the risk reward is good - if it succeeds it will be 1000% up but if it fails only 100% down. Plus it has a few shots at success - Activ 2 / Phase III international (why they picked 20 countries beats me) and COPD. | mikro1 | |
| 16/4/2021 18:42 | Ha ha you wish! | hazl | |
| 16/4/2021 18:35 | Not looking good is it | judijudi | |
| 16/4/2021 17:49 | Well it's risen at the end of the day so there's plenty of interest. Also there is a larger percentage bought by these people compared to Polar's reduction. Polygon Global Partners LLP Reade Eugene Griffith resulting in over 5% London, United Kingdom | hazl | |
| 16/4/2021 17:09 | Polar still selling. | wetdream | |
| 16/4/2021 17:00 | [Removed at request of original poster] | the real capitalcity | |
| 16/4/2021 16:43 | Thanks to posters on LSE and some twitter . | hazl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
